arcadia

DR. REDDYS LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE2621.8529.9 (+1.15 %)
PREV CLOSE ( ) 2591.95
OPEN PRICE ( ) 2569.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2621.85 (35)
VOLUME 37323
TODAY'S LOW / HIGH ( )2569.50 2628.40
52 WK LOW / HIGH ( )1888 2745
NSE2616.9522.15 (+0.85 %)
PREV CLOSE( ) 2594.80
OPEN PRICE ( ) 2580.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2616.95 (219)
VOLUME 946148
TODAY'S LOW / HIGH( ) 2575.30 2627.70
52 WK LOW / HIGH ( )1887 2749.95
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 24-02 1984
Management Info
K Satish Reddy - Chairman GV Prasad - Managing Director
Registered Office

Address 8-2-337, Road No. 3,Banjara Hills,,
Hyderabad,
Telangana-500034

Phone 040 - 4900 2900

Email sureshvs@drreddys.com ; shares@drreddys.com

Website www.drreddys.com

Registrars Details
Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, MCX, New York
NEWS
16Jan Fortis Healthcare, Dr. Reddy's Lab and
Fortis Healthcare has completed the acquisition of RHT Health Trust (RHT..
16Jan USFDA completes inspection at Dr. Redd
Untited state Food and Drug Administration (USFDA) has completed audit o..
16Jan Dr. Reddy's Laboratories informs about
Dr. Reddy's Laboratories has informed that the audit of the company’s Fo..
11Jan Dr. Reddy’s Laboratories informs about
Dr. Reddy’s Laboratories has informed about submission of a Press Releas..
27Dec Dr. Reddy's launches Sevelamer Carbona
Dr. Reddy's Laboratories has launched Sevelamer Carbonate for Oral Suspe..
Financials
Rs. in Millions
QTR Sep 18 ANNUAL 18
Net Profit34625669
Gross Profit 4328 6970
Operating Profit 639415339
Net Sales 2631093593
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
 6366.20 (2.22%)
M.Cap ( in Cr)14661.75
Eris Lifesciences (BSE)
 709.15 (9.96%)
M.Cap ( in Cr)9752.06
Torrent Pharma (BSE)
 1945.25 (2.84%)
M.Cap ( in Cr)32918.05
Piramal Enterprises (BSE)
 2367.35 (0.99%)
M.Cap ( in Cr)43420.10
Pfizer (BSE)
 2719.05 (0.77%)
M.Cap ( in Cr)12439.04
Shareholding Pattern
PROMOTERS 26.77%
NON-INSTITUTION 14.73%
MUTUAL FUNDS/UTI 12.12%
FI/BANKS/INSURANCE 5.71%
GOVERNMENT 0%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM